Feb 24, 2011 | Laboratory News, Laboratory Pathology
It’s a strong price to pay for this specialty clinical pathology laboratory company Today, Thermo Fisher Scientific Inc. (NYSE:TMO) announced that it was selling its Athena Diagnostics clinical pathology laboratory business to Quest Diagnostics Incorporated (NYSE:DGX). The purchase price will be $740 million, making this the highest-priced medical laboratory acquisition of 2011. Based in Worcester, Massachusetts, Athena Diagnostics is known for its expertise in diagnostic tests for...
Mar 3, 2010 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Clinical Pathology Laboratory Customers of Millipore Not Likely to See Many Changes It only took a few days for Millipore Corporation (NYSE: MIL) to find a buyer willing to outbid Thermo Fisher Scientific Inc. (NYSE: TMO). Millipore agreed to be acquired by Merck KGaA (FWB: MRK) of Darmstadt, Germany. Merck will pay about $7.2 billion for Millipore, which tops a reported bid of $6 billion made by Thermo Fisher last week. Because many clinical pathology laboratories use Millipore’s water...
Feb 25, 2010 | Laboratory News, Laboratory Pathology
Both companies are important suppliers to clinical laboratories and research labs In recent days, news surfaced that Thermo Fisher Scientific Inc. (NYSE: TMO) was offering $6 billion to acquire Millipore Corporation (NYSE:MIL). Neither company has confirmed the offer, but yesterday Millipore issued a statement that its Directors were “evaluating strategic options.” Should Thermo Fisher acquire Millipore, or should Millipore find another buyer, it will mean the same thing: more...
